Skip to main content
SLN logo

SLN

Silence Therapeutics plc
$9.95 -0.20 (-1.97%) At close · Jul 8
Market Cap
$1.41B
Shares
141,703,840

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$559K -98.7%
FY2025 Revenue FY2024–FY2025
Net Income
-$88.61M -95.6%
FY2025 Net Income FY2023–FY2025
Gross Margin
61.54% -11.2pp
FY2025 Gross Margin FY2024–FY2025
Operating Margin
-16292.84% -16146.5pp
FY2025 Operating Margin FY2024–FY2025
Diluted EPS
-$0.63 -90.9%
FY2025 Diluted EPS FY2024–FY2025
Operating Cash Flow
-$62.27M +7.9%
FY2025 Operating Cash Flow FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023
$839K $559K $43.26M
$172K $215K $11.81M
$667K $344K $31.45M
61.54% 72.7%
$56.06M $67.75M $67.88M
$21.69M $22.34M $26.88M
$1.32M
-$78.41M -$91.08M -$63.32M
-16292.84% -146.38%
-$75.03M -$88.6M -$44.46M
$11K $11K $845K
-$75.04M -$88.61M -$45.31M -$54.23M
-15851.52% -104.74%
-$70.32M -$79.81M -$46.36M
USD/shares -$0.63 -$0.33
USD/shares -$0.63 -$0.33
shares 141.69M 138.75M
shares 141.69M 138.75M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31
United Kingdom $559,000 $43,114,000 $30,934,000 $20,940,000
Germany $144,000 $709,000 $715,000

By Product & Service (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Research Collaboration Income $559,000 $43,114,000 $30,933,000 $20,940,000
Royalty Income $0 $144,000 $710,000 $715,000
Key facts CIK 1479615 CUSIP 82686Q101 13F (30d) 1 filings 1 filers Visit website Investor relations